Active, not recruitingPhase 3NCT01933724
The Assessment of Prednisone In Remission Trial (TAPIR) - Patient Centric Approach
Studying Granulomatosis with polyangiitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of South Florida
- Principal Investigator
- Peter A Merkel, MD, MPH, MD, MPHUniversity of Pennsylvania
- Intervention
- 5 mg prednisone(drug)
- Enrollment
- 12 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2014 – 2025
Study locations (1)
- University of South Florida TAPIR Study Team, Tampa, Florida, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01933724 on ClinicalTrials.govOther trials for Granulomatosis with polyangiitis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT06940661Obinutuzumab for Remission Induction in Patients With Relapsing PR3-ANCA Granulomatosis With PolyangiitisAssistance Publique - Hôpitaux de Paris
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT03919435TEMPO Study: Trimethoprim-Sulfamethoxazole in Granulomatosis With PolyangiitisUniversity of Pennsylvania